The TZM.bl cells used for neutralization assays are HIV-1 permissive reporter HeLa cells modified to express the receptor (human CD4) and co-receptors (human CCR5 and CXCR4), allowing the virus to initiate infection in these cells (84). Here, AQP1 is linked to infection.